APA

Dasmahapatra G., Lembersky D., Son M. P., Patel H., Peterson D., Attkisson E., Fisher R. I., Friedberg J. W., Dent P. & Grant S. (20130218). Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivo. : Molecular cancer therapeutics.

Chicago

Dasmahapatra Girija, Lembersky Dmitry, Son Minkyeong P, Patel Hiral, Peterson Derick, Attkisson Elisa, Fisher Richard I, Friedberg Jonathan W, Dent Paul and Grant Steven. 20130218. Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivo. : Molecular cancer therapeutics.

Harvard

Dasmahapatra G., Lembersky D., Son M. P., Patel H., Peterson D., Attkisson E., Fisher R. I., Friedberg J. W., Dent P. and Grant S. (20130218). Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivo. : Molecular cancer therapeutics.

MLA

Dasmahapatra Girija, Lembersky Dmitry, Son Minkyeong P, Patel Hiral, Peterson Derick, Attkisson Elisa, Fisher Richard I, Friedberg Jonathan W, Dent Paul and Grant Steven. Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivo. : Molecular cancer therapeutics. 20130218.